MOH said it will provide an update when it is ready, with a decision expected to be made in 2026. Read more at straitstimes.com. Read more at straitstimes.com.

Alphyn, a clinical-stage dermatology company developing the first Multi-Target Therapeutics (R) drug platform, announced today that it has completed enrollment in its CLEAR-AD1 Phase 2b clinical trial ...

Lebrikizumab improved disease severity, skin clearance and symptom relief in children with moderate to severe atopic dermatitis, according to topline results from a phase 3 trial. “Dupilumab [Dupixent ...

If none of your atopic dermatitis treatments have worked, you may be experiencing burnout (or treatment fatigue). Here's what ...

Eli Lilly scored $408 million in U.S. sales of eczema treatment Ebglyss in its first full year on the market in 2025. | With ...

If you've seen a surge of videos about how to use a derma roller for hair growth on social media recently, you're not alone. The skin care tool is trending for its scalp stimulating benefits. But are ...

Phase 3 data show lebrikizumab improves skin clearance and itch in children with moderate to severe atopic dermatitis, ...

Michelle Smith was told she had eczema as a teenager, but as the years went on her skin became 'so much worse' - until ...

A YOUNG dad who used a commonly prescribed cream for a year has told how he was left “screaming in agony” and bedbound for six months after suffering a horrific reaction when he ...

Lebrikizumab delivered significant skin clearance and improved disease severity in children with moderate-to-severe atopic dermatitisADorable-1 met co-primary efficacy endpoints, with 63% of ...

Please provide your email address to receive an email when new articles are posted on . More than 30 cases of TMVII were recently reported in Minnesota. The infection can mimic eczema, psoriasis and ...